FRA:SMZ1 (Hong Kong)  
Sino Biopharmaceutical Ltd logo

Sino Biopharmaceutical Ltd

€ 0.54 (+2%) Feb 3
On watch
P/E:
9.82
P/B:
2.47
Market Cap:
€ 10.27B ($ 11.12B)
Enterprise V:
€ 9.77B ($ 10.58B)
Volume:
-
Avg Vol (2M):
6.81K
Also Trade In:
Volume:
-
Market Cap €:
10.27B
Market Cap $:
11.12B
PE Ratio:
9.82
Avg Vol (2-Month):
6.81K
Enterprise Value €:
9.77B
Enterprise Value $:
10.58B
PB Ratio:
2.47

Business Description

Description
Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.